EBS vs AMZN: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

AMZN has stronger fundamentals based on our AI analysis.

EBS
Emergent BioSolutions Inc.
BUY
72%
Confidence
VS
AMZN
AMAZON COM INC
BUY
81%
Confidence

EBS vs AMZN Fundamental Comparison

Metric EBS AMZN
Revenue $742.9M $716.9B
Net Income $52.6M $77.7B
Net Margin 7.1% 10.8%
ROE 10.1% 18.9%
ROA 4.0% 9.5%
Current Ratio 5.01x 1.05x
Debt/Equity 1.13x 0.17x
EPS $0.93 $7.17

Green = Better metric | Red = Weaker metric

View Full EBS Analysis →
View Full AMZN Analysis →

You Might Also Compare

EBS vs AAPL AMZN vs MSFT EBS vs GOOGL AMZN vs NVDA

EBS vs AMZN: Frequently Asked Questions

Is EBS or AMZN a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), AMZN has stronger fundamentals. EBS is rated BUY (72% confidence) while AMZN is rated BUY (81% confidence). This is not investment advice.

How does EBS compare to AMZN fundamentally?

Emergent BioSolutions Inc. has ROE of 10.1% vs AMAZON COM INC's 18.9%. Net margins are 7.1% vs 10.8% respectively.

Which stock pays higher dividends, EBS or AMZN?

EBS has a dividend yield of N/A or no dividend while AMZN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in EBS or AMZN for long term?

For long-term investing, consider that EBS has BUY rating with 72% confidence, while AMZN has BUY rating with 81% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about EBS vs AMZN?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For EBS vs AMZN, the AI consensus favors AMZN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.